Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New 4-in-1 shot tested to protect kids from deadly meningitis

NCT ID NCT07135986

Recruiting now ⭐️ VACCINE ⭐️ Sponsor: Sanofi Source: ClinicalTrials.gov ↗

Summary

This study is testing a new vaccine designed to protect against four major strains of meningococcal disease, a serious and sometimes deadly bacterial infection. It will involve about 1,602 healthy children and adolescents in China to see how well their immune systems respond and to monitor for any side effects. The new vaccine is being compared to currently licensed meningococcal vaccines.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Investigational Site Number : 1561000

    RECRUITING

    Nanning, Guangxi, 530028, China

  • Investigational Site Number : 1561003

    RECRUITING

    Liuchow, 545100, China

Conditions

Explore the condition pages connected to this study.